Investor Ayer Capital Management, LP
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Ayer Capital Management, LP . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2015-05-20 13G/A IOVA / Iovance Biotherapeutics, Inc. 2,823,333
2013-06-03 13G IOVA / Iovance Biotherapeutics, Inc. 560,401,150
2013-05-06 13G/A NSPR / InspireMD, Inc. 855,924
2013-05-06 13G/A CDMO / Avid Bioservices, Inc. 643,935
2013-03-22 13G/A US0909311062 / BioSpecifics Technologies Corp. 0
2013-02-15 13G/A NSPR / InspireMD, Inc. 1,587,442
2013-02-15 13G/A CASC / Cascadian Therapeutics, Inc. 2,097,331
2013-02-15 13G/A ONCS / OncoSec Medical Inc 4,411,609
2013-02-15 13G/A ABEO / Abeona Therapeutics Inc. 1,207,417
2013-02-15 13G/A CDMO / Avid Bioservices, Inc. 7,441,442
2013-02-15 13G/A CLSN / Imunon Inc 1,747,145
2013-02-15 13G/A INSV / Insite Vision Inc 6,584,357
2013-02-15 13G/A IMUC / EOM Pharmaceuticals Holdings, Inc. 2,089,088
2012-12-07 13G/A INSM / Insmed Incorporated 1,541,469
2012-12-04 13G/A CDMO / Avid Bioservices, Inc. 5,743,030
2012-12-03 13G CDMO / Avid Bioservices, Inc. 3,743,030
2012-10-26 13G/A ABEO / Abeona Therapeutics Inc. 1,925,433
2012-10-04 13G INSM / Insmed Incorporated 3,116,100
2012-10-04 13G/A CDMO / Avid Bioservices, Inc. 0
2012-09-24 13G NSPR / InspireMD, Inc. 3,467,711
2012-09-11 13G 0
2012-08-23 13G/A RPTP / Raptor Pharmaceutical Corp. 61,729
2012-08-23 13G/A UPI / Uroplasty Inc 0
2012-08-08 13G CDMO / Avid Bioservices, Inc. 5,610,236
2012-04-04 13G/A ALBO / Albireo Pharma Inc 541,666
2012-04-04 13G/A CASC / Cascadian Therapeutics, Inc. 4,124,816
2012-04-04 13G/A IOVA / Iovance Biotherapeutics, Inc. 2,400,000
2012-04-04 13G/A SVRA / Savara Inc. 1,001,238
2012-04-04 13G/A ABEO / Abeona Therapeutics Inc. 2,758,620
2012-04-04 13G/A CLSN / Imunon Inc 3,146,129
2012-04-04 13G/A INSV / Insite Vision Inc 7,000,000
2012-04-04 13G/A UPI / Uroplasty Inc 1,182,562
2012-04-03 13G ONCS / OncoSec Medical Inc 5,000,000
2012-02-21 13G ADMA / ADMA Biologics, Inc. 364,585
2012-01-20 13G IMUC / EOM Pharmaceuticals Holdings, Inc. 2,818,181